The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.68
Bid: 15.50
Ask: 15.52
Change: 0.36 (2.35%)
Spread: 0.02 (0.129%)
Open: 14.88
High: 15.70
Low: 14.86
Prev. Close: 15.32
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of new bond issue

13 Oct 2022 07:00

RNS Number : 7163C
EnQuest PLC
13 October 2022
 

 

 

EnQuest PLC, 12 October 2022

 

Pricing of new bond issue

 

EnQuest PLC ("EnQuest" or the "Company") is pleased to announce it has agreed a successful refinancing of its existing $792.3 million senior notes due 2023, which will position it well to continue to deliver its strategy.

 

Specifically, EnQuest has:

 

· Priced the offering of new $305.0 million 11⅝% senior notes due 2027 (the "New Notes") due for settlement on 25 October 2022, at an issue price of 98.611%; and

 

· Agreed an amended and restated reserve-based lending ("RBL") facility at $500.0 million with a $300.0 million accordion and a final maturity in April 2027, upon settlement of the New Notes.

 

The above follows on from EnQuest's successful refinancing of its Sterling bond in April 2022, where it issued £133.3 million of bonds with a maturity of October 2027.

 

EnQuest will repay all of its existing $792.3 million senior notes due 2023, funded by (i) the proceeds of the New Notes, (ii) $400.0 million of drawings under the RBL facility and (iii) cash on hand.

 

Within the amended and restated RBL facility, Double A Limited, a company beneficially owned by the extended family of Amjad Bseisu, has agreed to lend $15.0 million on the same terms and conditions as all other lending parties. This is considered a smaller related party transaction under Listing Rule 11.1.10. EnQuest has obtained written confirmation from a sponsor that the terms of Double A's participation in the RBL facility are fair and reasonable as far as EnQuest's shareholders are concerned.

 

* * *

The Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws and may not be offered or sold in the United States or for the account or benefit of any US person or in any way distributed in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The Notes will be offered only to qualified institutional buyers in the United States in accordance with Rule 144A under the Securities Act and to non-US persons outside the United States in reliance on Regulation S under the Securities Act.

This announcement does not constitute an offer to sell or a solicitation of an offer to buy the Notes and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction where the offering would not be permitted. This announcement contains information about a pending transaction and there can be no assurance that this transaction will be completed.

 

Forward-Looking Information is Subject to Risk and Uncertainty

This announcement may include certain "forward-looking" statements. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words "believes," "expects," "may," "will," "would," "should," "seeks," "pro forma," "anticipates," "intends," "plans," "estimates," or the negative of any thereof or other variations thereof or comparable terminology, or by discussions of strategy or intentions. These statements are not guarantees of future actions or performance and involve risks, uncertainties and assumptions as to future events that may not prove to be accurate. Actual actions or results may differ materially from what is expressed or forecasted in these forward-looking statements as the Company may be unable to complete the Transactions. As a result, these statements speak only as of the date they were made and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Many important factors could cause the Company's results to differ materially from those expressed in these forward-looking statements. These factors include, but are not limited to, general market conditions, national or global events affecting the capital markets, the coronavirus disease (COVID-19) outbreak, unforeseen developments in the Company's business or industry or changes in law or regulations governing the Company's ability to complete the Transactions.

***********************************

This announcement is not being made in and copies of it may not be distributed or sent into any jurisdiction in which the publication, distribution or release would be unlawful.

This document is not an offer of securities for sale in the United States. The Notes may not be sold in the United States absent registration or an exemption from registration under the Securities Act. The Company does not intend to register the Notes and any related guarantees in the United States or to conduct a public offering of the Notes and such guarantees in the United States.

In member states of the EEA, this announcement and any offer of the securities referred to herein in any Member State of the European Economic Area ("EEA") will be made pursuant to an exemption under the Prospectus Regulation from the requirement to publish a prospectus for offers of the securities referred to herein. Accordingly, any person making or intending to make an offer in a Member State of Notes which are the subject of the offering contemplated may only do so in circumstances in which no obligation arises for the Company or any of the initial purchasers to publish a prospectus pursuant to Article 3 of the Prospectus Regulation, in each case, in relation to such offer. Neither the Company nor the initial purchasers have authorized, nor do they authorize, the making of any offer of Notes in circumstances in which an obligation arises for the Company or the initial purchasers to publish a prospectus for such offer. The expression "Prospectus Regulation" means Regulation (EU) 2017/1129.

The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the EEA. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, "MiFID II") or (ii) a customer within the meaning of Directive 2016/97/EU (as amended), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the "PRIIPs Regulation") for offering or selling the securities or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the securities or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPS Regulation.

The securities are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom ("UK"). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ("EUWA"); or (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (as amended, the "UK PRIIPs Regulation") for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.

In the UK, this announcement and any offer of the securities referred to herein in the UK will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to publish a prospectus for offers of the securities referred to herein. Accordingly, any person making or intending to make an offer in the UK of Notes which are the subject of the offering contemplated may only do so in circumstances in which no obligation arises for the Company or any of the initial purchasers to publish a prospectus pursuant to Article 3 of the UK Prospectus Regulation, in each case, in relation to such offer. Neither the Company nor the initial purchasers have authorized, nor do they authorize, the making of any offer of Notes in circumstances in which an obligation arises for the Company or the initial purchasers to publish a prospectus for such offer. The expression "UK Prospectus Regulation" means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA.

This communication is being distributed only to, and is directed at persons who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Financial Promotion Order") (ii) are persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order, (iii) are outside the United Kingdom or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 in connection with the issue and sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons")). This announcement is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement. The distribution of this announcement into certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. This announcement is an advertisement and is not a prospectus for the purposes of the Prospectus Regulation or the UK Prospectus Regulation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBCBDGUDBDGDD
Date   Source Headline
26th Apr 20243:00 pmRNSAnnual Financial Report
28th Mar 20247:01 amRNSResults for the year ended 31 December 2023
28th Mar 20247:00 amRNSDirectorate Change
28th Feb 202411:22 amRNSTotal Voting Rights
15th Feb 20247:00 amRNSFebruary Operations Update
30th Jan 202410:00 amRNSTermination of reporting issuer status in Canada
28th Dec 202310:01 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSSale of 15% of Bressay and EnQuest Producer FPSO
20th Dec 20234:46 pmRNSHolding(s) in Company
18th Dec 20234:00 pmRNSDirector Change
11th Dec 202311:34 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSDirectorate Change - EnQuest New Energy Leadership
5th Dec 20233:30 pmRNSConfirmation of delisting date
5th Dec 20239:30 amRNSSubmission of delisting application
4th Dec 20235:34 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSEnQuest November Operations Update
24th Nov 20239:00 amRNSApplication for Block Listing
30th Oct 20234:50 pmRNSDirector/PDMR Shareholding
30th Oct 20232:00 pmRNSNasdaq Stockholm delisting update
28th Sep 20233:00 pmRNSHolding(s) in Company
26th Sep 202310:03 amRNSPDMR Notification
13th Sep 202311:04 amRNSDirectorate Change
5th Sep 20237:02 amRNSNasdaq Stockholm delisting application
5th Sep 20237:01 amRNSBoard appointment
5th Sep 20237:00 amRNSHalf-year Results
25th Aug 20232:09 pmRNSTerm loan facility agreement
19th Jul 20232:20 pmRNSDirector/PDMR Shareholding
22nd Jun 202312:06 pmRNSReport on Payments to Govts
6th Jun 20239:02 amRNSResult of AGM
5th Jun 20233:00 pmRNSHolding(s) in Company
24th May 20237:00 amRNSEnQuest May Operations Update
18th May 20232:30 pmRNSEnQuest awarded offer of carbon storage licences
9th May 20237:00 amRNSEnQuest Malaysia Update
28th Apr 20232:00 pmRNSNotice of AGM
25th Apr 20239:00 amRNSAnnual Financial Report
13th Apr 20234:54 pmRNSDirectorate Change
5th Apr 20237:00 amRNSResults for the year ended 31 December 2022
17th Mar 20237:00 amRNS2022 Preliminary Results - revised date
15th Mar 202311:00 amRNSHolding(s) in Company
17th Feb 20237:00 amRNSTrading Statement
20th Dec 20221:35 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.